Trials / Completed
CompletedNCT04479098
Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors
Effects of Training and Detraining on Body Composition and Inflammatory, Oxidative and Lipid Profiles of Postmenopausal Breast Cancer Survivors Undergoing Tamoxifen Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Federal University of Uberlandia · Academic / Other
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The present study aimed to verify the effects of resistance exercise training and successive detraining on body composition, lipid profile, muscle strength, oxidative stress, and inflammatory markers of postmenopausal breast cancer survivors undergoing tamoxifen treatment.
Detailed description
The present study aimed to verify the effects of 12 weeks of resistance exercise training and successive 12 weeks of detraining on body composition (Body Mass, Body Mass Index, Fat Mass, and Fat-Free Mass), lipid profile (Triglycerides, Total Cholesterol, LDL-Cholesterol, HDL-Cholesterol), muscle strength (1RM test), oxidative stress (Thiobarbituric acid reactive substances,Non-Protein Thiols, Catalase activity, and Superoxide Dismutase), and inflammatory markers (Interferon γ, Tumor Necrosis Factor α, interleukin 6 , Adiponectin, and Interleukin 4) of postmenopausal breast cancer survivors undergoing tamoxifen treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Resistance exercise training | The exercise training program will last 12 weeks, with a frequency of three sessions per week, held on Mondays, Wednesdays, and Fridays. Each session will last approximately 50 minutes. Whenever the maximum number of pre-established repetitions is successfully performed, the intensity will be increased by 5 to 10%. All sessions will be supervised by trained professionals. |
| OTHER | Exercise detraining | The exercise detraining will last 12 weeks without exercise. |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-07-31
- Completion
- 2018-06-30
- First posted
- 2020-07-21
- Last updated
- 2020-07-21
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04479098. Inclusion in this directory is not an endorsement.